Shots: Scripps Research to receive up front, development & commercialization milestones, option exercise fee and royalties on sales of new therapies and will conduct pre-clinical R&D activities and P-I studies […]readmore
Tags : Multiple Therapeutic Areas
Shots: Evotec to receive upfront, up to $170M pre/clinical & commercial milestones per program with royalties on sales of products. Takeda to get access to utilize Evotec’s platform to discover […]readmore